+ Blood and lymphatic system disorders | Blood | Current |
+ Cardiac disorders | Card | Current |
+ Congenital, familial and genetic disorders | Cong | Current |
+ Ear and labyrinth disorders | Ear | Current |
+ Endocrine disorders | Endo | Current |
+ Eye disorders | Eye | Current |
+ Gastrointestinal disorders | Gastr | Current |
+ General disorders and administration site conditions | Genrl | Current |
+ Hepatobiliary disorders | Hepat | Current |
+ Immune system disorders | Immun | Current |
+ Infections and infestations | Infec | Current |
+ Injury, poisoning and procedural complications | Inj&P | Current |
+ Investigations | Inv | Current |
+ Metabolism and nutrition disorders | Metab | Current |
+ Musculoskeletal and connective tissue disorders | Musc | Current |
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neopl | Current |
+ Breast neoplasms benign (incl nipple) | | Current |
+ Breast neoplasms malignant and unspecified (incl nipple) | | Current |
+ Cancer-related morbidities | | Non-Current |
+ Cutaneous neoplasms benign | | Current |
+ Endocrine neoplasms benign | | Current |
+ Endocrine neoplasms malignant and unspecified | | Current |
+ Gastrointestinal neoplasms benign | | Current |
+ Gastrointestinal neoplasms malignant and unspecified | | Current |
+ Haematopoietic neoplasms (excl leukaemias and lymphomas) | | Current |
+ Hepatic and biliary neoplasms benign | | Current |
+ Hepatobiliary neoplasms malignant and unspecified | | Current |
+ Leukaemias | | Current |
+ Lymphomas Hodgkin's disease | | Current |
+ Lymphomas NEC | | Current |
+ Lymphomas non-Hodgkin's B-cell | | Current |
- Lymphomas non-Hodgkin's T-cell | | Current |
+ Adult T-cell lymphomas/leukaemias | | Current |
+ Anaplastic large cell lymphomas T- and null-cell types | | Current |
+ Angiocentric lymphomas | | Current |
+ Angioimmunoblastic T-cell lymphomas | | Current |
+ Intestinal T-cell lymphomas | | Current |
- Mycoses fungoides | | Current |
+ Mycosis fungoides | | Current |
+ Mycosis fungoides recurrent | | Current |
+ Mycosis fungoides refractory | | Current |
+ Mycosis fungoides stage I | | Current |
+ Mycosis fungoides stage II | | Current |
+ Mycosis fungoides stage III | | Current |
+ Mycosis fungoides stage IV | | Current |
+ Peripheral T-cell lymphomas NEC | | Current |
+ Precursor T-lymphoblastic lymphomas/leukaemias | | Current |
+ T-cell unclassifiable lymphomas | | Current |
+ Lymphomas non-Hodgkin's unspecified histology | | Current |
+ Mesotheliomas | | Current |
+ Metastases | | Current |
+ Miscellaneous and site unspecified neoplasms benign | | Current |
+ Miscellaneous and site unspecified neoplasms malignant and unspecified | | Current |
+ Neoplasm related morbidities | | Current |
+ Nervous system neoplasms benign | | Current |
+ Nervous system neoplasms malignant and unspecified NEC | | Current |
+ Ocular neoplasms | | Current |
+ Plasma cell neoplasms | | Current |
+ Renal and urinary tract neoplasms benign | | Current |
- Renal and urinary tract neoplasms malignant and unspecified | | Current |
- Bladder neoplasms malignant | | Current |
+ Bladder adenocarcinoma recurrent | | Current |
+ Bladder adenocarcinoma stage 0 | | Current |
+ Bladder adenocarcinoma stage I | | Current |
+ Bladder adenocarcinoma stage II | | Current |
+ Bladder adenocarcinoma stage III | | Current |
+ Bladder adenocarcinoma stage IV | | Current |
+ Bladder adenocarcinoma stage unspecified | | Current |
+ Bladder cancer | | Current |
+ Bladder cancer recurrent | | Current |
+ Bladder cancer stage 0, with cancer in situ | | Current |
+ Bladder cancer stage 0, without cancer in situ | | Current |
+ Bladder cancer stage I, with cancer in situ | | Current |
+ Bladder cancer stage I, without cancer in situ | | Current |
+ Bladder cancer stage II | | Current |
+ Bladder cancer stage III | | Current |
+ Bladder cancer stage IV | | Current |
+ Bladder squamous cell carcinoma recurrent | | Current |
+ Bladder squamous cell carcinoma stage 0 | | Current |
+ Bladder squamous cell carcinoma stage I | | Current |
+ Bladder squamous cell carcinoma stage II | | Current |
+ Bladder squamous cell carcinoma stage III | | Current |
+ Bladder squamous cell carcinoma stage IV | | Current |
+ Bladder squamous cell carcinoma stage unspecified | | Current |
+ Bladder transitional cell carcinoma | | Current |
+ Bladder transitional cell carcinoma metastatic | | Current |
+ Bladder transitional cell carcinoma recurrent | | Current |
+ Bladder transitional cell carcinoma stage 0 | | Current |
+ Bladder transitional cell carcinoma stage I | | Current |
+ Bladder transitional cell carcinoma stage II | | Current |
+ Bladder transitional cell carcinoma stage III | | Current |
+ Bladder transitional cell carcinoma stage IV | | Current |
+ Metastatic carcinoma of the bladder | | Current |
+ Neuroendocrine carcinoma of the bladder | | Current |
+ Non-renal cell kidney neoplasms malignant | | Non-Current |
- Renal cell carcinomas | | Non-Current |
+ Renal neoplasms malignant | | Current |
+ Renal pelvis and ureter neoplasms malignant | | Current |
+ Urinary tract neoplasms malignant NEC | | Current |
+ Urinary tract neoplasms unspecified malignancy NEC | | Current |
+ Reproductive and genitourinary neoplasms gender unspecified NEC | | Current |
+ Reproductive neoplasms female benign | | Current |
+ Reproductive neoplasms female malignant and unspecified | | Current |
+ Reproductive neoplasms male benign | | Current |
+ Reproductive neoplasms male malignant and unspecified | | Current |
+ Respiratory and mediastinal neoplasms benign (excl mesotheliomas) | | Current |
- Respiratory and mediastinal neoplasms malignant and unspecified | | Current |
+ Hypopharyngeal neoplasms malignant and unspecified | | Current |
+ Laryngeal neoplasms malignancy unspecified | | Current |
+ Laryngeal neoplasms malignant | | Current |
+ Mediastinal neoplasms malignancy unspecified NEC | | Current |
+ Mediastinal neoplasms malignant | | Current |
- Non-small cell neoplasms malignant of the respiratory tract cell type specified | | Current |
+ Adenosquamous cell lung cancer | | Current |
+ Adenosquamous cell lung cancer recurrent | | Current |
+ Adenosquamous cell lung cancer stage 0 | | Current |
+ Adenosquamous cell lung cancer stage I | | Current |
+ Adenosquamous cell lung cancer stage II | | Current |
+ Adenosquamous cell lung cancer stage III | | Current |
+ Adenosquamous cell lung cancer stage IV | | Current |
+ Large cell lung cancer | | Current |
+ Large cell lung cancer metastatic | | Current |
+ Large cell lung cancer recurrent | | Current |
+ Large cell lung cancer stage 0 | | Current |
+ Large cell lung cancer stage I | | Current |
+ Large cell lung cancer stage II | | Current |
+ Large cell lung cancer stage III | | Current |
+ Large cell lung cancer stage IV | | Current |
+ Lung adenocarcinoma | | Current |
+ Lung adenocarcinoma recurrent | | Current |
+ Lung adenocarcinoma stage 0 | | Current |
+ Lung adenocarcinoma stage I | | Current |
+ Lung adenocarcinoma stage II | | Current |
+ Lung adenocarcinoma stage III | | Current |
+ Lung adenocarcinoma stage IV | | Current |
+ Lung squamous cell carcinoma metastatic | | Current |
+ Lung squamous cell carcinoma recurrent | | Current |
+ Lung squamous cell carcinoma stage 0 | | Current |
+ Lung squamous cell carcinoma stage I | | Current |
+ Lung squamous cell carcinoma stage II | | Current |
+ Lung squamous cell carcinoma stage III | | Current |
+ Lung squamous cell carcinoma stage IV | | Current |
+ Non-small cell lung cancer | | Current |
+ Non-small cell lung cancer metastatic | | Current |
+ Non-small cell lung cancer recurrent | | Current |
+ Non-small cell lung cancer stage 0 | | Current |
+ Non-small cell lung cancer stage I | | Current |
+ Non-small cell lung cancer stage II | | Current |
+ Non-small cell lung cancer stage III | | Current |
+ Non-small cell lung cancer stage IIIA | | Current |
+ Non-small cell lung cancer stage IIIB | | Current |
+ Non-small cell lung cancer stage IV | | Current |
+ Squamous cell carcinoma of lung | | Current |
+ Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified | | Current |
+ Paranasal sinus and nasal cavity neoplasms malignant and unspecified | | Current |
+ Pharyngeal neoplasms malignant and unspecified | | Current |
+ Respiratory tract and pleural neoplasms malignancy unspecified NEC | | Current |
+ Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | | Current |
+ Respiratory tract small cell carcinomas | | Current |
+ Skeletal neoplasms benign | | Current |
+ Skeletal neoplasms malignant and unspecified | | Current |
+ Skin neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms benign | | Current |
+ Soft tissue neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms malignant and unspecified (excl sarcomas) | | Current |
+ Soft tissue sarcomas | | Current |
+ Nervous system disorders | Nerv | Current |
+ Pregnancy, puerperium and perinatal conditions | Preg | Current |
+ Product issues | Prod | Current |
+ Psychiatric disorders | Psych | Current |
+ Renal and urinary disorders | Renal | Current |
+ Reproductive system and breast disorders | Repro | Current |
+ Respiratory, thoracic and mediastinal disorders | Resp | Current |
+ Skin and subcutaneous tissue disorders | Skin | Current |
+ Social circumstances | SocCi | Current |
+ Surgical and medical procedures | Surg | Current |
+ Vascular disorders | Vasc | Current |
Standard View
|